Our Services
Medical Information
Helpful Resources
Published on: 9/26/2026
Xarelto (rivaroxaban) can, in rare cases, cause drug-induced liver injury, with warning signs such as yellowing of the skin or eyes, dark urine, unusual fatigue, nausea, or pain in the upper right abdomen, most often within the first few weeks to months of starting treatment. Because of this, clinicians generally check liver enzymes (ALT, AST) and bilirubin before starting and periodically afterward, along with kidney function, hemoglobin, and signs of bleeding, since impaired liver or kidney clearance raises drug levels and bleeding risk. Several factors change how closely you need monitoring, including existing liver disease, alcohol use, and other medications, so review the complete details below before drawing conclusions about your own situation.
If you have noticed jaundice, fatigue, dark urine, abdominal discomfort, or unexpected bruising while taking a blood thinner, those symptoms deserve a prompt, structured evaluation rather than guesswork, because some causes are harmless and others need urgent care. Take a free, instant, online symptom check to see which possibilities fit your pattern and get clear guidance on what to do next.
Last reviewed for medical accuracy: 09/26/2026
Xarelto (rivaroxaban) is an oral anticoagulant used to prevent and treat blood clots. Because it’s processed by the liver, many people ask: will Xarelto have an effect on my liver or cause liver damage? In most cases, serious liver injury is rare. However, monitoring and awareness help keep you safe. Below we explain what the research shows, how your body handles Xarelto, and what tests and signs your doctor will watch.
Key points from prescribing data:
Although serious cases are uncommon, you may wonder whether Xarelto could harm your liver over time. Here’s what studies and real-world experience show:
Take-home message: for the vast majority of users, Xarelto’s benefits in preventing dangerous clots far exceed the low chance of liver enzyme changes. Still, it’s smart to stay informed and follow your doctor’s recommendations.
Certain factors can make your liver more vulnerable while taking Xarelto:
If any of these apply, your doctor may monitor you more closely or choose a different blood thinner.
To catch any early signs of stress or damage, physicians often order routine labs:
Monitoring schedule:
Besides lab tests, be alert for any symptoms that could suggest liver strain:
If you notice any of these signs, reach out to your healthcare provider right away.
While the idea of liver damage can sound alarming, remember:
Staying proactive with appointments and lab work helps you and your doctor keep risks low.
Beyond liver tests, some additional checks include:
These assessments, combined with liver tests, create a full picture of how you’re tolerating treatment.
If you’re concerned about liver health or experience any worrying symptoms:
Your healthcare team can tailor an approach that balances clot prevention with liver safety.
Speak to a doctor if you experience any serious or life-threatening symptoms—such as severe abdominal pain, sudden jaundice, or uncontrollable bleeding—while taking Xarelto. Always rely on your physician’s guidance for personalized advice and treatment.
(References)
* Samama MM, Gerotziafas G. [New antitoagulants]. Ann Pharm Fr. 2007 Mar;65(2):85-94. doi: 10.1016/s0003-4509(07)90021-8. PMID: 17404541.
* Van Cott EM, Khor B, Zehnder JL. Factor V Leiden. Am J Hematol. 2016 Jan;91(1):46-9. doi: 10.1002/ajh.24222. Epub 2015 Nov 17. PMID: 26492443.
* Rivaroxaban: liver injury. Prescrire Int. 2015 Nov;24(165):268. PMID: 26688900.
* Christopoulou EC, Filippatos TD, Elisaf MS. Non-hemorrhage-related adverse effects of rivaroxaban. Arch Med Sci Atheroscler Dis. 2017;2:e108-e112. doi: 10.5114/amsad.2017.72533. Epub 2017 Dec 31. PMID: 29379891; PMCID: PMC5777473.
* Verheyen E, Kileci JA, Mathew JP. Single-Dose Rivaroxaban-Induced Acute Liver Injury. Am J Ther. 2019 Jul/Aug;26(4):e538-e540. doi: 10.1097/MJT.0000000000000799. PMID: 29889676.
* Rivaroxaban. 2012. PMID: 31643347.
* Antithrombotic Agents. 2012. PMID: 31643990.
* Abrignani MG, Gatta L, Gabrielli D, Milazzo G, De Francesco V, De Luca L, Francese M, Imazio M, Riccio E, Rossini R, Scotto di Uccio F, Soncini M, Zullo A, Colivicchi F, Di Lenarda A, Gulizia MM, Monica F. Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO). Eur J Intern Med. 2021 Mar;85:1-13. doi: 10.1016/j.ejim.2020.11.014. Epub 2020 Dec 2. PMID: 33279389.
* Juneja D, Nasa P, Jain R. Liver injury from direct oral anticoagulants. World J Hepatol. 2023 Jun 27;15(6):841-849. doi: 10.4254/wjh.v15.i6.841. PMID: 37397936; PMCID: PMC10308284.
* Puente Á, Turón F, Martínez J, Fortea JI, Guerra MH, Alvarado E, Pons M, Magaz M, Llop E, Alvarez-Navascués C, Navarrete AA, Berenguer M, Masnou H, Bañares R, Casado M, Ampuero J, Rios J, Saavedra C, Blasi A, Lisman T, Figuero CR, Huelin P, Tellez L, Arráez DM, Rodriguez M, Aguilera V, Arias Loste MT, Baiges A, Hernandez-Gea V, Perelló C, Calleja JL, Genescà J, Villanueva C, Gonzalez-Alayón C, Albillos A, Crespo J, García-Pagán JC. Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study. J Hepatol. 2025 Nov;83(5):1069-1076. doi: 10.1016/j.jhep.2025.06.035. Epub 2025 Jul 19. PMID: 40691992.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.